D073-0190 Screening compound: N-(2-{1-methyl-5-[2-(4-methyl-1-oxo-1,2-dihydrophthalazin-2-yl)acetamido]-1H-1,3-benzodiazol-2-yl}ethyl)propanamide

D073-0190 Screening compound: N-(2-{1-methyl-5-[2-(4-methyl-1-oxo-1,2-dihydrophthalazin-2-yl)acetamido]-1H-1,3-benzodiazol-2-yl}ethyl)propanamide
D073-0190 Screening compound: N-(2-{1-methyl-5-[2-(4-methyl-1-oxo-1,2-dihydrophthalazin-2-yl)acetamido]-1H-1,3-benzodiazol-2-yl}ethyl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D073-0190
N-(2-{1-methyl-5-[2-(4-methyl-1-oxo-1,2-dihydrophthalazin-2-yl)acetamido]-1H-1,3-benzodiazol-2-yl}ethyl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D073-0190

Molecular Formula

C24H26N6O3 (C24 H26 N6 O3)

Compound Name

N-(2-{1-methyl-5-[2-(4-methyl-1-oxo-1,2-dihydrophthalazin-2-yl)acetamido]-1H-1,3-benzodiazol-2-yl}ethyl)propanamide

IUPAC name

N-(2-{1-methyl-5-[2-(4-methyl-1-oxo-12-dihydrophthalazin-2-yl)acetamido]-1H-13-benzodiazol-2-yl}ethyl)propanamide

SMILES

CCC(NCCc1nc(cc(cc2)NC(CN3N=C(C)c(cccc4)c4C3=O)=O)c2n1C)=O

InChI

InChI=1S/C24H26N6O3/c1-4-22(31)25-12-11-21-27-19-13-16(9-10-20(19)29(21)3)26-23(32)14-30-24(33)18-8-6-5-7-17(18)15(2)28-30/h5-10,13H,4,11-12,14H2,1-3H3,(H,25,31)(H,26,32)

InChI Key

IEYZXESGHYZWEJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06601721

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.667

Distribution Coefficient, logD

1.562

Water Solubility, LogSw

-2.75

Polar Surface Area

86.089

Acid Dissociation Constant (pKa)

12.91

Base Dissociation Constant (pKb)

6.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

D073-0190 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D073-0190 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D073-0190?
Check Price and Availability of D073-0190, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D073-0190 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D073-0190
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D073-0190
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D073-0190 available by request